Prostate Neoplasms Completed Phase 2 Trials for Trebananib (DB12056)

Also known as: Neoplasm, Prostate / Neoplasms, Prostate / Prostate Neoplasm

IndicationStatusPhase
DBCOND0031071 (Prostate Neoplasms)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01553188AMG 386 and Abiraterone for Advanced Prostate CancerTreatment